Medrhans Pharmaceuticals Private Limited, a active private limited company, was established on 10 December 2018 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74990TG2018PTC128888. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.22 Cr.
It upholds a compliant status. Its leadership includes Vanga Kondalreddy (Director), Chiranjeevi Gadupudi (Director), Venkateswarlu Nalajala (Director). Past directors included Gopi Krishna Bobbala. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plotno:91,Road No:4,Second Floor Himapuri Colony,Mansoorabad,Lb Nagar, Hyderabad, Telangana, 500068.
U74990TG2018PTC128888
128888
10 December 2018
₹3.00 Cr
₹2.22 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Medrhans Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vanga Kondalreddy | Director | 10 Dec 2018 | Current |
| Chiranjeevi Gadupudi | Director | 10 Dec 2018 | Current |
| Venkateswarlu Nalajala | Director | 10 Dec 2018 | Current |
| Gopi Krishna Bobbala | Director | 08 Jul 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 28 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medrhans Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 87.24% increase. The company also saw a substantial fall in profitability, with a 33.26% decrease in profit. The company's net worth Soared by an impressive increase of 33.91%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Medrhans Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Medrhans Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medrhans Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medrhans Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Medrhans Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Medrhans Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.
Progress on Gopi Krishna Bobbala was appointed as a Director was appointed as a Director on 08 Jul 2019 & has been associated with this company since 6 years 5 months . was documented.
The activity Vanga Kondalreddy was appointed as a Director was appointed as a Director on 10 Dec 2018 & has been associated with this company since 7 years 15 days . was completed.
Chiranjeevi Gadupudi was appointed as a Director was appointed as a Director on 10 Dec 2018 & has been associated with this company since 7 years 15 days . was recorded as a recent event.
Progress on Venkateswarlu Nalajala was appointed as a Director was appointed as a Director on 10 Dec 2018 & has been associated with this company since 7 years 15 days . was documented.
The CIN of Medrhans Pharmaceuticals Private Limited is U74990TG2018PTC128888.
Medrhans Pharmaceuticals Private Limited is headquartered at Plotno:91,Road No:4,Second Floor Himapuri Colony,Mansoorabad,Lb Nagar, Hyderabad, Telangana, 500068.
Medrhans Pharmaceuticals Private Limited was incorporated on 10 December 2018.
The current directors of Medrhans Pharmaceuticals Private Limited are
The primary industry of Medrhans Pharmaceuticals Private Limited is Trade.
Medrhans Pharmaceuticals Private Limited is unlisted.
The authorized capital of Medrhans Pharmaceuticals Private Limited is ₹3.00 Cr, and the paid-up capital is ₹2.22 Cr.
The compliance status of Medrhans Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX